Posted by Michael Wonder on 19 Mar 2023
Lower drug prices are a good thing. Canada’s approach to achieving them was not.
17 March 2023 - Over the past six years, the Patented Medicine Prices Review Board – Canada’s federal drug-price regulating agency – has sought to impose lower drug costs when new pharmaceuticals are introduced here.
But the main achievement of that crusade is that fewer new medicines are now available to Canadians.
